Lifeway Foods (NYSE:LWAY) stock price target bumped up to $17.00, reported earlier today by D. A. Davidson
- Updated: September 16, 2016
D. A. Davidson bumped the estimated target of Lifeway Foods (NYSE:LWAY) to $17, indicating a possible upside of 0.12%.
Previously on Friday December 11 2015, D. A. Davidson reported on Lifeway Foods(NYSE:LWAY) raised the target price from $0.00 to $14.00. At the time, this suggested an upside of 0.21%.
Boasting a price of $15.24, Lifeway Foods (NYSE:LWAY) traded 6.25% higher on the day. The last stock close is up 46.29% relative to the two hundred day moving average, compared to the S&P 500 which has decreased -0.01% over the date range. Lifeway Foods has recorded a 50-day average of $11.38 and 200-day moving average of $10.46. 47,586 shares of LWAY traded, up from ann avg. trading volume of 14,248
See Graph Below:
Lifeway Foods has a 52 week low of $8.68 and a one-year high of $15.47 with a price-earnings ratio of 58 and has a market capitalization of $0.0.
General Information About Lifeway Foods (NYSE:LWAY)
Lifeway Foods, Inc. (Lifeway) is engaged in the manufacturing of probiotic, cultured, functional dairy health food products. The Company is engaged in the sale of fermented dairy products, which are produced and are sold to consumers through a network of distributors and retailers in the United States. Through its distributors, the Company also sells its products to retailers in Mexico, Costa Rica, Dubai, Hong Kong, China and the Caribbean. The Company’s primary product is kefir, a dairy beverage similar to but distinct from yogurt, in various flavors and in various package configurations. In addition to the drinkable products, Lifeway manufactures Lifeway Farmer Cheese, a line of various farmer cheeses. Kefir also serves as a base for lower-calorie dressings, dips, marinades, and soups or sauces and as a basic ingredient in other home-prepared foods. Recipes are made available through the Company’s Website. The Company also markets and sells its ProBugs line of drinkable kefir.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.